Biogen's Singhal On Stepping Into R&D Leadership Shoes Amid Aduhelm Controversy

 
• By Jessica Merrill
  
Priya Singhal
Biogen interim head of RYD Priya Singhal • Source: Pharma Intelligence / Biogen
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Leadership

More from Scrip